Article 6N7RW Are We Closer to a Cure for Diabetes?

Are We Closer to a Cure for Diabetes?

by
EditorDavid
from Slashdot on (#6N7RW)
"Chinese scientists develop cure for diabetes," reads the headline from the world's second-most widely read English-language newspaper. ("Insulin patient becomes medicine-free in just 3 months.") The researchers' results were published earlier in May in Cell Discovery, and are now getting some serious scrutiny from the press. The Economic Times cites a University of British Columbia professor's assessment that the study "represents an important advance in the field of cell therapy for diabetes," in an article calling it a "breakthrough" that "marks a significant advancement in cell therapy for diabetes."Chinese scientists have successfully cured a patient's diabetes using a groundbreaking cell therapy... According to a South China Morning Post report, the patient underwent the cell transplant in July 2021. Remarkably, within eleven weeks, he no longer required external insulin. Over the next year, he gradually reduced and ultimately stopped taking oral medication for blood sugar control. "Follow-up examinations showed that the patient's pancreatic islet function was effectively restored," said Yin, one of the lead researchers. The patient has now been insulin-free for 33 months... The new therapy involves programming the patient's peripheral blood mononuclear cells, transforming them into "seed cells" to recreate pancreatic islet tissue in an artificial environment. Their article calls it "a significant medical milestone" - noting that 140 million people in China have diabetes (according to figures from the International Diabetes Federation). Thanks to long-time Slashdot reader AmiMoJo for sharing the news.

twitter_icon_large.pngfacebook_icon_large.png

Read more of this story at Slashdot.

External Content
Source RSS or Atom Feed
Feed Location https://rss.slashdot.org/Slashdot/slashdotMain
Feed Title Slashdot
Feed Link https://slashdot.org/
Feed Copyright Copyright Slashdot Media. All Rights Reserved.
Reply 0 comments